Generated by All in One SEO v4.9.7.2, this is an llms.txt file, used by LLMs to index the site. # Centrexion Therapeutics Solving unmet needs with a proven track record. ## Sitemaps - [XML Sitemap](https://centrexion.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Hello world!](https://centrexion.com/hello-world/) - Welcome to WordPress. This is your first post. Edit or delete it, then start writing! ## Pages - [Home](https://centrexion.com/) - Solving unmet needs with a proven track record. We’re a dynamic company led by experienced leaders in the industry who are strategically building a portfolio with powerful opportunities in two emerging and growing categories: non-opioid pain relief and immunology. - [Team](https://centrexion.com/team/) - Our senior management team has broad and deep leadership experience at companies with substantial product development success and understands the complexity of designing and executing clinical trials for developing pain therapies. - [Privacy Policy](https://centrexion.com/privacy-policy/) - Privacy Policy This Privacy Policy was last updated on November 3, 2015. Our Policy: Welcome to the website (the “Website”) of Centrexion Therapeutics (“Centrexion”, “we”, “us” and/or “our”). This Website is operated by Centrexion and has been created to provide information about our company and its products and services (the “Centrexion Services”) to our Website - [Contact](https://centrexion.com/contact/) - Our people, expertise, and pipeline position us for success. With our strategic focus on key markets with unmet needs, Centrexion is ready to transform the ways in which pain and immunology are treated. - [Terms of Use](https://centrexion.com/terms-of-use/) - Terms Of Use Agreement Effective: 2/08/2016 1. Acceptance of the Terms and Conditions. 1.1 Centrexion Therapeutics (herein referred to as Centrexion, we, us or our) provides and makes available this website (the Website). All use of the Website is subject to the terms and conditions contained in this Terms of Use Agreement (the Agreement). Please read this Agreement carefully. By - [Pipeline](https://centrexion.com/pipeline/) - We have a broad and diversified pipeline of novel, non-opioid clinical stage medicines for the treatment of chronic pain. With our deep understanding of the underlying pathophysiology of chronic pain, we have developed a pipeline of drug candidates that are specific to both the type and source of pain. ## Staff - [Charles Oh, M.D.](https://centrexion.com/staff-member/charles-oh/) - Charles Oh, M.D., serves as the Chief Medical Officer at Centrexion Therapeutics. He joined Centrexion as Senior Vice President, Clinical and Medical, in September 2025 with over 20 years of experience in clinical development and medical affairs. Prior to joining Centrexion, he served as the Chief Medical Officer of Corium, LLC. Previously, he held senior - [Niti Goel, M.D.](https://centrexion.com/staff-member/niti-goel-m-d/) - Niti Goel, M.D., is a board-certified rheumatologist and physician-scientist with over 25 years of industry experience who discerns the clinical and market potential of new molecules and products, focused on getting them approved, prescribed, and in the hands of the people who need them. She currently serves as a clinical consultant to Centrexion and is - [Sarah Kelly](https://centrexion.com/staff-member/sarah-kelly/) - Sarah Kelly serves as vice president of Corporate Development at Centrexion Therapeutics, where she leads business development strategy, licensing efforts, portfolio prioritization, and commercial strategy. She brings more than two decades of experience in business development, all aspects of commercialization, and product planning across emerging biotech, global pharmaceutical companies, and medical devices. Sarah has held - [Randall Stevens, M.D.](https://centrexion.com/staff-member/randall-stevens-m-d/) - Randall Stevens, M.D. joined Centrexion Therapeutics as the chief medical officer in April 2015, and led Centrexion’s clinical, medical, and regulatory operations through 2025. Randall is a board-certified internist and rheumatologist with more than 25 years of experience in pharmaceutical medicine. Prior to joining Centrexion, he served as the corporate vice president, head of inflammation - [Mike Ward](https://centrexion.com/staff-member/mike-ward/) - Mike Ward joined Centrexion Therapeutics as CFO in 2019. He brings more than 25 years of experience, predominantly as an investment banker focused on life sciences and as both CFO and CBO of public and private life sciences companies. Prior to joining Centrexion, Mike served as CFO and CBO of Bionano Genomics, a NASDAQ-listed life - [James N. Campbell, M.D.](https://centrexion.com/staff-member/james-n-campbell-m-d/) - James Campbell, M.D. is a founder, president and chief scientific officer of Centrexion Therapeutics. Jim is Professor Emeritus of neurosurgery at Johns Hopkins University School of Medicine. He has published over 100 peer-reviewed scientific studies in the field of pain research, which have been recognized through many national honors. In 1996, Jim was president of - [Smital Shah](https://centrexion.com/staff-member/smital-shah/) - Smital Shah has over two decades of senior management experience in the biopharma and investment banking industries focused on financial strategy, capital markets, and business development. She currently has her own CFO/CBO advisory practice and consults with several biotech companies on finance/BD/operations strategy. She also served as board member and chair of the audit committees - [Jonathan Guerriero](https://centrexion.com/staff-member/jonathan-guerriero/) - Jonathan joined Centrexion in June 2019 bringing two decades of leadership, program development and clinical operations experience in the pharmaceutical and biotech industry. Jonathan has held positions of increasing responsibility leading development programs in early phase through post-approval, starting up and managing clinical operations functions, and working in clinical development. Prior to joining Centrexion, Jonathan - [Jeffrey B. Kindler](https://centrexion.com/staff-member/jeffrey-b-kindler/) - Jeff Kindler joined Centrexion Therapeutics as the chief executive officer in 2013. He brings more than three decades of business experience and has held leadership positions at some of the world’s most recognized companies. Jeff is also executive chair of vTv Therapeutics, venture partner at Lux Capital, managing director at Starboard Capital and the global - [Shawn Tomasello](https://centrexion.com/staff-member/shawn-tomasello/) - Shawn Tomasello joined the Centrexion Therapeutics board of directors in 2017. With over 30 years of experience in the pharmaceutical and biotech industries, Shawn currently serves as chief commercial officer of Kite Pharma. Prior to her role at Kite Pharma, Shawn served as chief commercial officer at Pharmacyclics, Inc., preceding its acquisition by AbbVie, Inc. - [Joseph R. Swedish](https://centrexion.com/staff-member/joseph-r-swedish/) - Joseph R. Swedish is the former Chairman, President and CEO of Anthem, Inc, (currently Elevance Health) a Fortune 22 company and the nation’s leading health benefits provider. This became the foundation for Elevance Health today serving nearly 47.3 million members – or one in seven Americans – through its affiliated health plans, and over 117 - [Colin Hill](https://centrexion.com/staff-member/colin-hill/) - Colin Hill is a leading voice in healthcare technology and precision medicine and brings impressive leadership experience in commercializing machine learning technologies in the biopharmaceutical and managed care industries. He co-founded GNS Healthcare, a leading AI-driven precision medicine company, in 2000 and has since served as CEO. In 2020 the company launched Gemini — The in - [Sol Barer, Ph.D.](https://centrexion.com/staff-member/sol-barer-ph-d/) - Sol Barer, Ph.D. is a founder and chairman of the board of directors of Centrexion Therapeutics. Sol brings more than 30 years of experience in the biotechnology industry. He is the managing partner of SJBarer Consulting and was a founder of Celgene, a global biopharmaceutical company. From 1987 to 2011, Sol led Celgene in various ## Categories - [Uncategorized](https://centrexion.com/category/uncategorized/) ## Staff Categories - [Board of Directors](https://centrexion.com/staff-category/board-of-directors/) - [Management Team](https://centrexion.com/staff-category/management-team/)